Accelerate Diagnostics, Inc. (AXDX) Financials

AXDX Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 39.3 million 74.4 million
2023-06-30 49.9 million 88.5 million
2023-03-31 51.0 million 89.7 million
2022-12-31 65.0 million 87.3 million

AXDX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -9.0 million 1.8 million
2023-06-30 -11.0 million 1.7 million
2023-03-31 -13.4 million 555000
2022-12-31 -9.7 million 2.4 million

AXDX Net Income

No data available :(

AXDX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 21.2 million - 2.5 million
2023-06-30 30.7 million 32.3 million 3.6 million
2023-03-31 31.9 million - 4.0 million
2022-12-31 45.6 million 49.6 million 4.3 million

AXDX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 14.6 million
2023-06-30 11.0 million
2023-03-31 9.8 million
2022-12-31 6.2 million

AXDX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 758000 7.0 million 7.8 million -
2023-06-30 155000 5.8 million 7.6 million -
2023-03-31 12000 7.0 million 10.1 million -
2022-12-31 108000 6.0 million 8.3 million -

AXDX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 3.3 million 3.2 million
2023-06-30 2.9 million 2.1 million
2023-03-31 2.8 million 1.8 million
2022-12-31 3.0 million 2.3 million

AXDX

Price: $0.92

52 week price:
0.74
11.90

Earnings Per Share: -5.52 USD

P/E Ratio: -0.20

Exchange: NCM

Sector: Healthcare

Industry: Medical Devices

Volume: 335200

Ebitda: -16.0 million

Market Capitalization: 19.2 million

Links: